Filing excerpt
partially offset by 14% lower net selling price, reflecting the ongoing impact of U.S. Medicare Part D price setting effective in 2026 under the Inflation Reduction Act, and lower volume.
Source: Autobound Signal API · 83 signals tracked for Amgen · updated
Get Amgen's live signals in Claude or ChatGPT, or by API
What changed at Amgen this week? Use Autobound signals for amgen.com.The company reported an ongoing impact from U.S. Medicare Part D price setting effective in 2026 mandated under the Inflation Reduction Act. Compliance with federal drug price negotiations may drive Amgen to invest in regulatory compliance, government reporting, and pricing analytics tools.
Filing excerpt
partially offset by 14% lower net selling price, reflecting the ongoing impact of U.S. Medicare Part D price setting effective in 2026 under the Inflation Reduction Act, and lower volume.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-8kcomplianceBurdenGet every 8-K signal for Amgen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/63d51da8-727b-4cc6-a361-403def583781 returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.
{
"signal_id": "63d51da8-727b-4cc6-a361-403def583781",
"signal_type": "sec-8k",
"signal_subtype": "complianceBurden",
"detected_at": "2026-11-10T07:04:15.941+00:00",
"company": {
"name": "Amgen",
"domain": "amgen.com"
},
"data": {
"detail": "The company reported an ongoing impact from U.S. Medicare Part D price setting effective in 2026 mandated under the Inflation Reduction Act. Compliance with federal drug price negotiations may drive Amgen to invest in regulatory compliance, government reporting, and pricing analytics tools.",
"metrics": {
"pct": -0.14,
"timeframe": "current_year",
"pct_context": "lower net selling price impact"
},
"summary": "U.S. Medicare Part D price setting effective in 2026 under Inflation Reduction Act impacts Enbrel pricing",
"excerpts": "partially offset by 14% lower net selling price, reflecting the ongoing impact of U.S. Medicare Part D price setting effective in 2026 under the Inflation Reduction Act, and lower volume.",
"relevance": 0.7,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000153/amgn-20261103.htm",
"filing_date": "2026-11-03",
"filing_year": 2026,
"fiscal_year_end": "11/03",
"sales_relevance": "GRC tools needed",
"signal_category": "risk",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/63d51da8-727b-4cc6-a361-403def583781 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"amgen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.